Brain Edema, Imaging Abnormalities Reported for Alzheimer's Drug

(MedPage Today) — Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early symptomatic Alzheimer’s disease, a secondary analysis of trial data showed.
In phase II and III trials of…

Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/114601

Author :

Publish date : 2025-03-11 19:03:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Brain Edema, Imaging Abnormalities Reported for Alzheimer’s Drug

Stress and Strokes; Gene Hackman’s CVD Death; PFO Closure for the Nickel-Sensitive

NHS screening error affects more than 5,000

Related Posts

China’s CO2 emissions have started falling – is this finally the peak?

Similar Relief From Cancer-Related Pain With Two Radiotherapy Techniques

RFK Jr. Hammered on Funding Cuts, HHS Overhaul at House Hearing

House Committee Holds Marathon Markup for Bill That Includes $715B in Medicaid Cuts

Here’s How We Know Vaccines Are Safe and Effective

Mucus-Plugged Airways Linked to COPD Outcomes

China’s CO2 emissions have started falling – is this finally the peak?

Similar Relief From Cancer-Related Pain With Two Radiotherapy Techniques

RFK Jr. Hammered on Funding Cuts, HHS Overhaul at House Hearing

House Committee Holds Marathon Markup for Bill That Includes $715B in Medicaid Cuts

Here’s How We Know Vaccines Are Safe and Effective

Mucus-Plugged Airways Linked to COPD Outcomes

Staffing Woes Tied to Physician Burnout

FDA OKs New Drug for Lung Cancer With c-Met Overexpression

Categories

Archives